Evidence map›Paper›PMID 30007239›Full record

ArticleEpilepsy research2018

Clinical topography relationship in patients with parenchymal neurocysticercosis and seizures.

Kevin R Duque, Alejandro L Escalaya, Willy Zapata, Jorge G Burneo, Javier A Bustos, Isidro Gonzales, Herbert Saavedra, E Javier Pretell, Hector H Garcia, Cysticercosis Working Group in Peru

Open access · greenAbstract read
In one paragraph

Article in Epilepsy research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Unique Characteristics of Epilepsy Development in Neurocysticercosis.The American journal of tropical medicine and hygiene · 2020
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Kevin R DuqueSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; Center for Global Health - Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru; Clinica San Felipe, Lima, Peru. Electronic address: kevin.duque@upch.pe.
Alejandro L EscalayaSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; Clinica San Felipe, Lima, Peru.
Willy ZapataDepartment of Epilepsy, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Jorge G BurneoEpilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine, Western University, London, Canada.
Javier A BustosCenter for Global Health - Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru.
Isidro GonzalesCysticercosis Unit, Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
Herbert SaavedraCysticercosis Unit, Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
E Javier PretellDepartment of Neurology, Hospital Nacional Alberto Sabogal, Lima, Peru.
Hector H GarciaCenter for Global Health - Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru; Cysticercosis Unit, Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Lima, Peru; Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru.
Cysticercosis Working Group in Peru
Centro Peruano de Estudios Sociales · PEInstituto Nacional de Ciencias NeurológicasUniversidad Peruana Cayetano Heredia · PEInstituto Nacional de Enfermedades Neoplásicas · PEWestern University · CA

Funding

Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
Scientific CoreU19AI129909 · NIAID · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GONZALEZ, ARMANDO EMILIANO · 2017 to 2021
$2.8M
Neurocysticercosis: Combined Treatment with Praziquantel and AlbendazoleR01NS054805 · NINDS · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · 2006 to 2012
$2.7M
Combined Albendazole and Praziquantel in Subarachnoid NCC, CCC, Lead applicationU01NS086974 · NINDS · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI BUSTOS, JAVIER A · 2015 to 2020
$2.2M
Use of bisphosphonates to reduce the calcification process in animal models of cysticercosisR01AI116456 · NIAID · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI BUSTOS, JAVIER A · 2015 to 2019
$651k
Characterization of hippocampal sclerosis in individuals with calcified NeurocysticercosisR21NS094976 · NINDS · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · 2016 to 2017
$342k
FIC NIH HHS D43 TW001140NIAID NIH HHS R01 AI116456NIAID NIH HHS U19 AI129909NINDS NIH HHS R01 NS054805NINDS NIH HHS R21 NS094976NINDS NIH HHS U01 NS086974
6 · The paper itself

Abstract

objectiveDiscordances between imaging findings of parenchymal neurocysticercosis and seizure expression have been reported, and as such the possibility that neurocysticercosis and seizures may frequently coexist by chance has been raised. In this study, we evaluate the topographic relationship between seizure foci based on semiology and electroencephalography with the location of parenchymal neurocysticercotic lesions.

methodsSeizure information, neuroimaging (computed tomography and magnetic resonance imaging [MRI]) and electroencephalographic data from three randomized clinical trials of individuals with parenchymal neurocysticercosis and focal seizures were analyzed. Blinded epileptologists defined a potential seizure onset zone and a symptomatogenic zone for each individual based on semiology. The topographic relationship between semiology, either lesion location or areas of perilesional edema on baseline MRI, and electroencephalographic abnormalities were assessed.

resultsFifty-eight patients with one or two parenchymal neurocysticercotic lesions were included in this study. From them, 50 patients (86%; 95% CI, 75%-93%) showed a clinical-topography relationship with the potential seizure onset zone, and 44 (76%) also with the symptomatogenic zone. From the eight patients with no topographic relationship, five had focal seizures 30 days before or after the baseline MRI and showed perilesional edema. All of these five patients showed a clinical-topography relationship between such seizures and an area of perilesional edema, making a total of 55 patients (95%; 95% CI, 85%-99%) with clinical-topography relationship when perilesional edema is considered. Most patients with focal epileptiform discharges (7/8, 88%) had a topographic association between electroencephalographic focality, the potential seizure onset zone and a cysticercotic lesion.

conclusionSeizure semiology and focal epileptiform discharges are topographically related to neurocysticercotic lesions in most patients. These data strongly support seizure origin in the cortex surrounding these lesions.

Indexed as

AdolescentAdultAgedAntiparasitic AgentsBrainElectroencephalographyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeurocysticercosisRandomized Controlled Trials as TopicRetrospective StudiesSeizuresTomography Scanners, X-Ray ComputedAntiparasitic AgentsCysticercosisEpilepsyNeurocysticercosisPeruSeizuresTaenia solium

Identifiers

PMID30007239
PMCPMC7063828
OpenAlexW2811214767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.